Norbert G. Riedel - 27 Feb 2026 Form 4 Insider Report for Jazz Pharmaceuticals plc (JAZZ)

Role
Director
Signature
By: /s/Paz Dizon, as attorney in fact For: Norbert G. Riedel
Issuer symbol
JAZZ
Transactions as of
27 Feb 2026
Net transactions value
-$184,137
Form type
4
Filing time
02 Mar 2026, 17:36:59 UTC
Previous filing
05 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
RIEDEL NORBERT G Director 5TH FL, WATERLOO EXCHANGE, WATERLOO RD, DUBLIN 4, IRELAND By: /s/Paz Dizon, as attorney in fact For: Norbert G. Riedel 02 Mar 2026 0001161662

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction JAZZ Ordinary Shares Options Exercise $471,543 +3,415 +49% $138.08 10,439 27 Feb 2026 Direct
transaction JAZZ Ordinary Shares Sale $655,680 -3,415 -33% $192.00 7,024 27 Feb 2026 Direct
holding JAZZ Ordinary Shares 10,630 27 Feb 2026 by Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction JAZZ Non-Qualified Stock Option (right to buy) Options Exercise $0 -3,415 -100% $0.000000 0 27 Feb 2026 Ordinary Shares 3,415 $138.08 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This non-qualified stock option was granted on August 11, 2016 and vested over a period of one year from September 1, 2016. The options were fully vested as of August 1, 2017.